Index/Topics/Ivermectin Safety

Ivermectin Safety

The potential risks and side effects associated with ivermectin use

Fact-Checks

6 results
Jan 17, 2026
Most Viewed

How does ivermectin pharmacokinetics differ when taken with food versus fasting, and what are clinical implications?

A body of pharmacokinetic studies finds that taking oral ivermectin with food — especially a high‑fat meal — tends to increase systemic exposure (AUC and sometimes Cmax) compared with fasting, but the...

Jan 15, 2026

How does ivermectin interact with liver or kidney function?

Ivermectin is extensively metabolized by the liver and is eliminated mainly via feces rather than the kidneys, which helps explain why clinically significant renal clearance is minimal . Human pharmac...

Jan 13, 2026

What clinical trials exist for topical ivermectin in human dermatologic conditions beyond rosacea?

Topical ivermectin has robust, phase‑level clinical trial evidence for two dermatologic uses beyond rosacea: as a 0.5% lotion for head lice (pediatrics and adults) and as a 1% cream primarily studied ...

Jan 7, 2026

What laboratory assays and sensitivity thresholds are used to detect ivermectin in biological samples?

Modern laboratories detect ivermectin in blood, plasma, tissue and environmental matrices using a suite of chromatographic and immunoassay techniques; tandem mass spectrometry methods (LC–MS/MS or UHP...

Jan 5, 2026

How do concentrations of veterinary ivermectin products for horses differ from human formulations?

Veterinary ivermectin products for horses are manufactured in far higher-strength, differently formulated forms—such as concentrated oral pastes, large-dose injectables, and pour-on liquids—than human...

Jan 5, 2026

Are there safety or tissue‑residue differences when ivermectin is formulated with solubility enhancers like PVP or arabinogalactan?

Formulating ivermectin with solubility enhancers such as polyvinylpyrrolidone (PVP) or arabinogalactan (AG) reliably increases apparent solubility and bioavailability and can permit lower effective do...